Abstract

BackgroundThe Pharmaceutical Benefits Scheme (PBS) is Australia’s national drug subsidy program. This paper provides a practical guide to researchers using PBS data to examine prescribed medicine use.FindingsExcerpts of the PBS data collection are available in a variety of formats. We describe the core components of four publicly available extracts (the Australian Statistics on Medicines, PBS statistics online, section 85 extract, under co-payment extract). We also detail common analytical challenges and key issues regarding the interpretation of utilisation using the PBS collection and its various extracts.ConclusionsResearch using routinely collected data is increasing internationally. PBS data are a valuable resource for Australian pharmacoepidemiological and pharmaceutical policy research. A detailed knowledge of the PBS, the nuances of data capture, and the extracts available for research purposes are necessary to ensure robust methodology, interpretation, and translation of study findings into policy and practice.

Highlights

  • The Pharmaceutical Benefits Scheme (PBS) is Australia’s national drug subsidy program

  • The purpose of this paper is to provide a practical guide for researchers using Australia’s Pharmaceutical Benefits Scheme (PBS) dispensing data

  • The Drug Utilisation Sub-Committee (DUSC) database, which is the source of the Australian Statistics on Medicines (ASM) reports, combines the PBS/Repatriation Pharmaceutical Benefits Scheme (RPBS) dataset with estimates of non-subsidised prescription medicines use obtained from an ongoing Pharmacy Guild Survey of approximately 370 community pharmacies

Read more

Summary

Introduction

The Pharmaceutical Benefits Scheme (PBS) is Australia’s national drug subsidy program. When a PBS/RPBS medicine is dispensed, the administering pharmacy or hospital provides DHS with data pertaining to the prescription dispensed, identity of the patient, prescribing doctor, and supplying pharmacy.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call